Summary
Top ICT spenders in the Australian pharmaceutical Industry presents the output from Kable's ICT spend prediction statistical model, a log-linear regression model that provides ICT spending predictions based on a company's demographic profile. The statistical model has been developed using an extensive collection of survey and interview data that Kable has conducted with ICT decision makers on their IT spending, as well as the insight of our analyst team.
Key Findings
Top ICT spenders in the Australian pharmaceutical Industry illustrates how Kable expects the top ICT spenders in the Australian pharmaceutical industry to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, communications and consulting.
Synopsis
The predictions were formulated in March 2015 following a large survey of ICT decision makers. Estimated trends in ICT spending have been identified through to the end of 2015 following feedback from respondents on their forthcoming investment plans.
Reasons To Buy
- Understand how the Australian pharmaceutical industry enterprise ICT landscape is set to change in 2015 to prioritize your target market.
- Make effective business decisions by recognizing the opportunities within each of the core areas of ICT spend (hardware, software, IT services, telecommunications, and consulting) .
- Realign your sales initiatives by understanding the current strategic objectives of the Australian pharmaceutical industry enterprises.
- Enhance your market segmentation with the included, detailed breakdown of opportunities within selected technology categories (enterprise application, business intelligence, and security products).
Table Of Contents
1 Top-level ICT budget breakdowns
1.1 Introduction
2 Top ICT Spenders
3 CSL Limited
3.1 Estimated ICT budget breakdown by function
3.2 Estimated external ICT budget allocation by core technology area
3.3 Detailed ICT budget allocations
3.3.1 Estimated hardware budget breakdown
3.3.2 Estimated software budget breakdown by technology
3.3.3 Estimated software budget breakdown by type
3.3.4 Estimated IT services budget breakdown
3.3.5 Estimated IT consulting services budget breakdown
3.3.6 Estimated telecommunications budget breakdown
4 Sigma Pharmaceuticals Limited
4.1 Estimated ICT budget breakdown by function
4.2 Estimated external ICT budget allocation by core technology area
4.3 Detailed ICT budget allocations
4.3.1 Estimated hardware budget breakdown
4.3.2 Estimated software budget breakdown by technology
4.3.3 Estimated software budget breakdown by type
4.3.4 Estimated IT services budget breakdown
4.3.5 Estimated IT consulting services budget breakdown
4.3.6 Estimated telecommunications budget breakdown
5 Tasmanian Alkaloids Pty Ltd.
5.1 Estimated ICT budget breakdown by function
5.2 Estimated external ICT budget allocation by core technology area
5.3 Detailed ICT budget allocations
5.3.1 Estimated hardware budget breakdown
5.3.2 Estimated software budget breakdown by technology
5.3.3 Estimated software budget breakdown by type
5.3.4 Estimated IT services budget breakdown
5.3.5 Estimated IT consulting services budget breakdown
5.3.6 Estimated telecommunications budget breakdown
6 Johnson and Johnson Pty. Limited
6.1 Estimated ICT budget breakdown by function
6.2 Estimated external ICT budget allocation by core technology area
6.3 Detailed ICT budget allocations
6.3.1 Estimated hardware budget breakdown
6.3.2 Estimated software budget breakdown by technology
6.3.3 Estimated software budget breakdown by type
6.3.4 Estimated IT services budget breakdown
6.3.5 Estimated IT consulting services budget breakdown
6.3.6 Estimated telecommunications budget breakdown
7 Pfizer Australia Pty Limited
7.1 Estimated ICT budget breakdown by function
7.2 Estimated external ICT budget allocation by core technology area
7.3 Detailed ICT budget allocations
7.3.1 Estimated hardware budget breakdown
7.3.2 Estimated software budget breakdown by technology
7.3.3 Estimated software budget breakdown by type
7.3.4 Estimated IT services budget breakdown
7.3.5 Estimated IT consulting services budget breakdown
7.3.6 Estimated telecommunications budget breakdown
8 Merck Sharp and Dohme (Australia) Pty Limited
8.1 Estimated ICT budget breakdown by function
8.2 Estimated external ICT budget allocation by core technology area
8.3 Detailed ICT budget allocations
8.3.1 Estimated hardware budget breakdown
8.3.2 Estimated software budget breakdown by technology
8.3.3 Estimated software budget breakdown by type
8.3.4 Estimated IT services budget breakdown
8.3.5 Estimated IT consulting services budget breakdown
8.3.6 Estimated telecommunications budget breakdown
9 AstraZeneca Pty Limited
9.1 Estimated ICT budget breakdown by function
9.2 Estimated external ICT budget allocation by core technology area
9.3 Detailed ICT budget allocations
9.3.1 Estimated hardware budget breakdown
9.3.2 Estimated software budget breakdown by technology
9.3.3 Estimated software budget breakdown by type
9.3.4 Estimated IT services budget breakdown
9.3.5 Estimated IT consulting services budget breakdown
9.3.6 Estimated telecommunications budget breakdown
10 Sanofi-Aventis Australia Pty Ltd.
10.1 Estimated ICT budget breakdown by function
10.2 Estimated external ICT budget allocation by core technology area
10.3 Detailed ICT budget allocations
10.3.1 Estimated hardware budget breakdown
10.3.2 Estimated software budget breakdown by technology
10.3.3 Estimated software budget breakdown by type
10.3.4 Estimated IT services budget breakdown
10.3.5 Estimated IT consulting services budget breakdown
10.3.6 Estimated telecommunications budget breakdown
11 Aspen Pharmacare Australia Pty Limited
11.1 Estimated ICT budget breakdown by function
11.2 Estimated external ICT budget allocation by core technology area
11.3 Detailed ICT budget allocations
11.3.1 Estimated hardware budget breakdown
11.3.2 Estimated software budget breakdown by technology
11.3.3 Estimated software budget breakdown by type
11.3.4 Estimated IT services budget breakdown
11.3.5 Estimated IT consulting services budget breakdown
11.3.6 Estimated telecommunications budget breakdown
12 Alphapharm Pty Limited
12.1 Estimated ICT budget breakdown by function
12.2 Estimated external ICT budget allocation by core technology area
12.3 Detailed ICT budget allocations
12.3.1 Estimated hardware budget breakdown
12.3.2 Estimated software budget breakdown by technology
12.3.3 Estimated software budget breakdown by type
12.3.4 Estimated IT services budget breakdown
12.3.5 Estimated IT consulting services budget breakdown
12.3.6 Estimated telecommunications budget breakdown
13 Appendix
13.1 Definitions
13.2 Currency Conversion
13.3 Further reading
13.4 Contact the authors
List Of Tables
Table 1: Top ICT spenders in Australian pharmaceutical industry
Table 2: CSL Limited will spend an estimated AUD 25m on its data centre
Table 3: CSL Limited will spend an estimated AUD 27m on hardware
Table 4: CSL Limited will spend an estimated AUD 4m on clients
Table 5: CSL Limited will spend an estimated AUD 4m on application lifecycle
Table 6: CSL Limited will spend an estimated AUD 6m on software licenses
Table 7: CSL Limited will spend an estimated AUD 4m on application development and integration
Table 8: CSL Limited will spend an estimated AUD 5m on systems planning and design consulting
Table 9: CSL Limited will spend an estimated AUD 4m on wireless data
Table 10: Sigma Pharmaceuticals Limited will spend an estimated AUD 18m on its data centre
Table 11: Sigma Pharmaceuticals Limited will spend an estimated AUD 19m on hardware
Table 12: Sigma Pharmaceuticals Limited will spend an estimated AUD 3m on clients
Table 13: Sigma Pharmaceuticals Limited will spend an estimated AUD 3m on application lifecycle
Table 14: Sigma Pharmaceuticals Limited will spend an estimated AUD 4m on software licenses
Table 15: Sigma Pharmaceuticals Limited will spend an estimated AUD 3m on application development and integration
Table 16: Sigma Pharmaceuticals Limited will spend an estimated AUD 3m on systems planning and design consulting
Table 17: Sigma Pharmaceuticals Limited will spend an estimated AUD 3m on wireless data
Table 18: Tasmanian Alkaloids Pty Ltd. will spend an estimated AUD 11m on its data centre
Table 19: Tasmanian Alkaloids Pty Ltd. will spend an estimated AUD 11m on hardware
Table 20: Tasmanian Alkaloids Pty Ltd. will spend an estimated AUD 2m on clients
Table 21: Tasmanian Alkaloids Pty Ltd. will spend an estimated AUD 2m on enterprise applications
Table 22: Tasmanian Alkaloids Pty Ltd. will spend an estimated AUD 2m on software licenses
Table 23: Tasmanian Alkaloids Pty Ltd. will spend an estimated AUD 2m on application development and integration
Table 24: Tasmanian Alkaloids Pty Ltd. will spend an estimated AUD 2m on systems planning and design consulting
Table 25: Tasmanian Alkaloids Pty Ltd. will spend an estimated AUD 2m on fixed voice
Table 26: Johnson and Johnson Pty. Limited will spend an estimated AUD 10m on its data centre
Table 27: Johnson and Johnson Pty. Limited will spend an estimated AUD 10m on hardware
Table 28: Johnson and Johnson Pty. Limited will spend an estimated AUD 2m on clients
Table 29: Johnson and Johnson Pty. Limited will spend an estimated AUD 1m on application lifecycle
Table 30: Johnson and Johnson Pty. Limited will spend an estimated AUD 2m on software licenses
Table 31: Johnson and Johnson Pty. Limited will spend an estimated AUD 2m on application development and integration
Table 32: Johnson and Johnson Pty. Limited will spend an estimated AUD 2m on systems planning and design consulting
Table 33: Johnson and Johnson Pty. Limited will spend an estimated AUD 1m on wireless data
Table 34: Pfizer Australia Pty Limited will spend an estimated AUD 8m on its data centre
Table 35: Pfizer Australia Pty Limited will spend an estimated AUD 8m on hardware
Table 36: Pfizer Australia Pty Limited will spend an estimated AUD 1m on clients
Table 37: Pfizer Australia Pty Limited will spend an estimated AUD 1m on application lifecycle
Table 38: Pfizer Australia Pty Limited will spend an estimated AUD 2m on software licenses
Table 39: Pfizer Australia Pty Limited will spend an estimated AUD 1m on application development and integration
Table 40: Pfizer Australia Pty Limited will spend an estimated AUD 1m on systems planning and design consulting
Table 41: Pfizer Australia Pty Limited will spend an estimated AUD 1m on wireless data
Table 42: Merck Sharp and Dohme (Australia) Pty Limited will spend an estimated AUD 6m on its data centre
Table 43: Merck Sharp and Dohme (Australia) Pty Limited will spend an estimated AUD 6m on hardware
Table 44: Merck Sharp and Dohme (Australia) Pty Limited will spend an estimated AUD 1m on clients
Table 45: Merck Sharp and Dohme (Australia) Pty Limited will spend an estimated AUD 1m on application lifecycle
Table 46: Merck Sharp and Dohme (Australia) Pty Limited will spend an estimated AUD 1m on software licenses
Table 47: Merck Sharp and Dohme (Australia) Pty Limited will spend an estimated AUD 1m on application development and integration
Table 48: Merck Sharp and Dohme (Australia) Pty Limited will spend an estimated AUD 1m on systems planning and design consulting
Table 49: Merck Sharp and Dohme (Australia) Pty Limited will spend an estimated AUD 1m on fixed voice
Table 50: AstraZeneca Pty Limited will spend an estimated AUD 5m on its data centre
Table 51: AstraZeneca Pty Limited will spend an estimated AUD 6m on hardware
Table 52: AstraZeneca Pty Limited will spend an estimated AUD 1m on clients
Table 53: AstraZeneca Pty Limited will spend an estimated AUD 1m on enterprise applications
Table 54: AstraZeneca Pty Limited will spend an estimated AUD 1m on software licenses
Table 55: AstraZeneca Pty Limited will spend an estimated AUD 1m on application development and integration
Table 56: AstraZeneca Pty Limited will spend an estimated AUD 1m on systems planning and design consulting
Table 57: AstraZeneca Pty Limited will spend an estimated AUD 1m on wireless data
Table 58: Sanofi-Aventis Australia Pty Ltd. will spend an estimated AUD 6m on its data centre
Table 59: Sanofi-Aventis Australia Pty Ltd. will spend an estimated AUD 6m on hardware
Table 60: Sanofi-Aventis Australia Pty Ltd. will spend an estimated AUD 1m on clients
Table 61: Sanofi-Aventis Australia Pty Ltd. will spend an estimated AUD 1m on application lifecycle
Table 62: Sanofi-Aventis Australia Pty Ltd. will spend an estimated AUD 1m on software licenses
Table 63: Sanofi-Aventis Australia Pty Ltd. will spend an estimated AUD 1m on application development and integration
Table 64: Sanofi-Aventis Australia Pty Ltd. will spend an estimated AUD 1m on systems planning and design consulting
Table 65: Sanofi-Aventis Australia Pty Ltd. will spend an estimated AUD 1m on fixed voice
Table 66: Aspen Pharmacare Australia Pty Limited will spend an estimated AUD 5m on its data centre
Table 67: Aspen Pharmacare Australia Pty Limited will spend an estimated AUD 6m on hardware
Table 68: Aspen Pharmacare Australia Pty Limited will spend an estimated AUD 1m on clients
Table 69: Aspen Pharmacare Australia Pty Limited will spend an estimated AUD 1m on application lifecycle
Table 70: Aspen Pharmacare Australia Pty Limited will spend an estimated AUD 1m on software licenses
Table 71: Aspen Pharmacare Australia Pty Limited will spend an estimated AUD 1m on application development and integration
Table 72: Aspen Pharmacare Australia Pty Limited will spend an estimated AUD 1m on systems planning and design consulting
Table 73: Aspen Pharmacare Australia Pty Limited will spend an estimated AUD 1m on fixed voice
Table 74: Alphapharm Pty Limited will spend an estimated AUD 4m on its data centre
Table 75: Alphapharm Pty Limited will spend an estimated AUD 5m on hardware
Table 76: Alphapharm Pty Limited will spend an estimated AUD 1m on clients
Table 77: Alphapharm Pty Limited will spend an estimated AUD 1m on application lifecycle
Table 78: Alphapharm Pty Limited will spend an estimated AUD 1m on software licenses
Table 79: Alphapharm Pty Limited will spend an estimated AUD 1m on application development and integration
Table 80: Alphapharm Pty Limited will spend an estimated AUD 1m on systems planning and design consulting
Table 81: Alphapharm Pty Limited will spend an estimated AUD 1m on fixed voice
List Of Figures
Figure 1: Top ICT spenders in Australian pharmaceutical industry
